Cargando…
Persistence With Lipid-Lowering Therapy: Influence of the Type of Lipid-Lowering Agent and Drug Benefit Plan Option in Elderly Patients
OBJECTIVES: To determine the effects of lipid-lowering agent (LLA) class and drug plan design option on persistence with LLAs among elderly patients enrolled in a managed care plan. METHODS: A retrospective cohort study was conducted among 310 older adult members enrolled in a health maintenance org...
Autores principales: | Abughosh, Susan M., Kogut, Stephen J., Andrade, Susan E., Larrat, E. Paul, Gurwitz, Jerrry H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437439/ https://www.ncbi.nlm.nih.gov/pubmed/15369423 http://dx.doi.org/10.18553/jmcp.2004.10.5.404 |
Ejemplares similares
-
Novel Uses for Lipid-Lowering Agents
por: May, Megan Brafford, et al.
Publicado: (2016) -
Comparison of persistence rates of acetylcholine-esterase inhibitors in a state Medicaid program
por: Abughosh, Susan M, et al.
Publicado: (2008) -
Lipid-lowering therapy: who can benefit?
por: Lewis, Sandra J
Publicado: (2011) -
Role of lipid-lowering agents in the management of diabetic retinopathy
por: Ioannidou, Estelle, et al.
Publicado: (2017) -
Formulation and Evaluation of Nanocrystals of a Lipid Lowering Agent
por: Louis, Dina
Publicado: (2016)